tradingkey.logo
tradingkey.logo
Search

BioLine RX Ltd

BLRX
Add to Watchlist
2.820USD
+0.100+3.72%
Close 07-31 16:00ETQuotes delayed by 15 min
12.27MMarket Cap
LossP/E TTM

BLRX Financials

See BioLine RX Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

BioLine RX Ltd Earnings Date

Latest Release
May 27, 2026
EPS / Forecast
--/-0.52
Revenue / Forecast
--/410.00K
Period
FY2025 Earnings
Revenue(YoY)
1.18M
-95.92%
EPS(YoY)
-0.49
89.35%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Financial Indicators
EPS
65.57%-0.50
92.37%-0.22
-515.00%-1.00
460.94%1.39
81.04%-1.46
71.88%-2.91
101.99%0.24
95.14%-0.38
-107.58%-7.72
-86.69%-10.35
---12.05
---7.91
---3.72
---5.54
----
----
----
----
----
----
Revenue
-98.35%194.00K
-91.36%427.00K
-94.36%304.00K
-96.28%255.00K
144.77%11.75M
--4.94M
--5.39M
--6.86M
--4.80M
----
----
----
----
----
----
----
----
----
----
----
Net Profit
29.84%-2.24M
83.22%-977.00K
-914.05%-3.94M
836.64%5.13M
77.05%-3.19M
63.66%-5.82M
102.61%484.00K
94.28%-696.00K
-142.26%-13.88M
-134.01%-16.02M
-149.16%-18.55M
-146.69%-12.16M
-33.16%-5.73M
-19.79%-6.85M
-8.78%-7.44M
51.63%-4.93M
64.10%-4.30M
-23.78%-5.72M
-1.06%-6.84M
-53.38%-10.19M
Net Margin
-4149.02%-1152.58%
-94.26%-228.81%
-14541.34%-1296.05%
19902.57%2010.59%
90.62%-27.13%
---117.78%
--8.97%
---10.15%
---289.25%
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
64.78%79.38%
-3.65%80.33%
-8.46%76.32%
10.02%86.67%
108.70%48.17%
--83.37%
--83.37%
--78.77%
--23.08%
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
-35.81%24.81%
-49.09%28.59%
-39.80%29.13%
44.04%31.58%
113.20%38.66%
122.92%56.15%
110.66%48.39%
16.87%21.93%
12.38%18.13%
90.25%25.19%
--22.97%
--18.76%
--16.13%
--13.24%
----
----
----
----
----
----
Revenue
-98.35%194.00K
-91.36%427.00K
-94.36%304.00K
-96.28%255.00K
144.77%11.75M
--4.94M
--5.39M
--6.86M
--4.80M
----
----
----
----
----
----
----
----
----
----
----
Operating profit
0.88%-3.39M
59.03%-2.21M
60.11%-2.30M
50.41%-2.39M
71.20%-3.42M
56.41%-5.39M
41.78%-5.77M
45.55%-4.82M
-41.26%-11.86M
-74.58%-12.36M
-30.43%-9.91M
-45.68%-8.86M
-27.28%-8.40M
-13.85%-7.08M
-16.72%-7.60M
-11.56%-6.08M
-12.36%-6.60M
-33.73%-6.22M
-17.01%-6.51M
20.34%-5.45M
Net Profit
29.84%-2.24M
83.22%-977.00K
-914.05%-3.94M
836.64%5.13M
77.05%-3.19M
63.66%-5.82M
102.61%484.00K
94.28%-696.00K
-142.26%-13.88M
-134.01%-16.02M
-149.16%-18.55M
-146.69%-12.16M
-33.16%-5.73M
-19.79%-6.85M
-8.78%-7.44M
51.63%-4.93M
64.10%-4.30M
-23.78%-5.72M
-1.06%-6.84M
-53.38%-10.19M
Current assets
-12.63%23.68M
-24.64%28.52M
-35.12%31.86M
-10.57%31.92M
-42.56%27.10M
31.40%37.85M
41.56%49.11M
-19.48%35.69M
-9.27%47.18M
-50.29%28.80M
-21.34%34.69M
-12.98%44.33M
-9.41%52.00M
-7.80%57.94M
-34.25%44.10M
-14.17%50.94M
150.89%57.40M
193.36%62.85M
138.11%67.07M
168.08%59.35M
Total current liabilities
-21.31%12.12M
-45.24%13.67M
-49.28%15.48M
-55.28%14.03M
-50.06%15.41M
69.52%24.96M
145.19%30.52M
160.55%31.37M
188.90%30.85M
81.05%14.72M
29.22%12.45M
32.35%12.04M
9.88%10.68M
-21.14%8.13M
-2.87%9.63M
-10.94%9.10M
-8.66%9.72M
-1.56%10.31M
-15.41%9.92M
-13.17%10.22M
Total assets
5.14%40.91M
-24.53%39.80M
-33.02%43.27M
-15.68%43.51M
-39.14%38.91M
-0.21%52.74M
9.60%64.60M
-24.83%51.60M
-16.31%63.92M
-35.28%52.85M
-13.12%58.94M
-8.19%68.65M
-6.15%76.38M
-6.02%81.67M
-25.72%67.84M
-10.56%74.77M
72.11%81.39M
88.76%86.91M
72.35%91.33M
77.23%83.60M
Total liabilities
-30.99%17.56M
-54.18%20.27M
-54.17%23.20M
-41.24%22.65M
-49.81%25.45M
11.37%44.24M
33.61%50.62M
30.50%38.54M
98.50%50.70M
51.90%39.72M
236.13%37.88M
159.96%29.53M
91.99%25.54M
63.39%26.15M
-35.36%11.27M
-40.06%11.36M
-47.33%13.30M
-24.62%16.00M
-26.61%17.44M
1.55%18.95M
Total equity
73.43%23.34M
129.66%19.53M
43.57%20.07M
59.74%20.86M
1.80%13.46M
-35.24%8.51M
-33.59%13.98M
-66.61%13.06M
-73.99%13.22M
-76.35%13.13M
-62.78%21.05M
-38.32%39.11M
-25.33%50.84M
-21.69%55.52M
-23.45%56.57M
-1.91%63.41M
209.06%68.09M
185.80%70.90M
152.80%73.89M
126.77%64.65M
Net operating income
62.83%-3.20M
78.56%-2.11M
98.44%-177.00K
81.64%-2.59M
-272.51%-8.61M
0.77%-9.82M
-17.01%-11.33M
-76.01%-14.11M
187.82%4.99M
-14.04%-9.90M
-53.95%-9.68M
-43.50%-8.02M
-3.27%-5.68M
-73.19%-8.68M
7.89%-6.29M
10.32%-5.59M
-1.31%-5.50M
8.37%-5.01M
-22.70%-6.83M
7.55%-6.23M
Net investment
-103.02%-337.00K
-63.90%3.67M
57.15%-3.70M
-149.00%-8.18M
154.70%11.16M
148.35%10.18M
-177.88%-8.64M
151.23%16.69M
-628.09%-20.39M
127.43%4.10M
10.66%11.10M
31.58%6.64M
-3.40%3.86M
-37437.50%-14.94M
267.16%10.03M
113.92%5.05M
-53.20%4.00M
-99.47%40.00K
-7.01%-6.00M
-685.71%-36.26M
Net financing
-12.89%-1.25M
24.79%-916.00K
-93.29%1.60M
1157.05%9.45M
-109.45%-1.11M
-134.81%-1.22M
17920.15%23.88M
-1724.49%-894.00K
1914.53%11.74M
-84.60%3.50M
80.55%-134.00K
94.80%-49.00K
-471.84%-647.00K
1342.35%22.72M
-104.89%-689.00K
-102.25%-943.00K
-97.50%174.00K
250.29%1.57M
21.70%14.09M
10728.68%41.91M

FAQs

What is the total revenue of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its total revenue reached 1.18M, with a year-on-year change of 28.94M.

What are the current assets of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its current assets were 23.68M, with a year-on-year change of -12.63.

What are the total assets of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its total assets of BioLine RX Ltd were 40.91M, with a year-on-year change of 5.14.

What are the total liabilities of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its total liabilities of BioLine RX Ltd were 17.56M, with a year-on-year change of -30.99.

What is the total equity of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its total equity of BioLine RX Ltd was 23.34M, with a year-on-year change of 73.43.

What is the net operating income of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its net operating income of BioLine RX Ltd was -10.29M, with a year-on-year change of 46.97.

What is the net investment of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its net investment of BioLine RX Ltd was -8.54M, with a year-on-year change of -129.09.

What is the net financing of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its net financing of BioLine RX Ltd was 8.88M, with a year-on-year change of -56.99.

What is the Earnings Per Share (EPS) of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.49, with a year-on-year change of 89.35.

What is the net income of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its net income was -2.03M, with a year-on-year change of 78.03.

What is the net margin of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its net profit margin was -171.69, with a year-on-year change of -438.86.

What is the gross margin of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its gross margin was 80.51, with a year-on-year change of 18.41.

What is the debt-to-asset ratio of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its debt-to-asset ratio was 24.81, with a year-on-year change of -35.81.

What is the Return on Equity (ROE) of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its Return on Equity (ROE) was -12.80, with a year-on-year change of 81.48.

What is the Return on Assets (ROA) of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its Return on Assets (ROA) was -5.08, with a year-on-year change of 71.69.

What is the operating profit of BioLine RX Ltd?

According to BioLine RX Ltd's FY2025 earnings report, its operating profit was -10.29M, with a year-on-year change of 46.97.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.